Graham Smith

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Susan Swindells, Jaime Andrade‐Villanueva, Gary Richmond et al. · New England Journal of Medicine · 2020 · 523 citations · Full text

Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial

David A. Margolis, Cynthia Brinson, Graham Smith et al. · The Lancet Infectious Diseases · 2015 · 198 citations

Phase 2B, Human Retrovirus, Pharmacology +10

Maori Education: Revolution and Transformative Action

Graham Smith · Open Collections · 2021 · 106 citations · Full text

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2019 · 92 citations

Treatment And Prevention, Antiretroviral-naive Adults, Clinical Trials +6

“Do you guys hate Aucklanders too?” Youth: voicing difference from the rural heartland

Linda Tuhiwai Smith, Graham Smith, Megan Boler et al. · Journal of Rural Studies · 2002 · 70 citations

Culture, Community Development, Rural Heartland +9